Exploring GLP-1 and SGLT2 Medications

Type 2 diabetes is common. It accounts for over 90% of all diabetes, and has a prevalence of 8.5% in the US. And complications are common as well - from blindness to amputation to chronic kidney disease. So it is important that we get the diagnosis and management of this condition right. To find out more about this problem and what we can do about it, please do listen to this podcast interview with Gregg Simonson, Director of Professional Training at the International Diabetes Center at Park Nicollet Minneapolis. Competing interests: GS declares that his employer, HealthPartners Institute International Diabetes Center, has organizational interests that include receiving unrestricted educational grants from Abbott Diabetes Care and Sanofi.